Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CTKB NASDAQ:FEIM NASDAQ:LAB NYSE:OWLT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTKBCytek Biosciences$4.78+2.6%$4.46$2.37▼$6.18$601.80M1.22571,972 shs793,359 shsFEIMFrequency Electronics$56.22+6.2%$50.63$16.77▼$61.47$521.03M0.53165,312 shs175,006 shsLABStandard BioTools$0.98+4.7%$0.97$0.87▼$1.72$364.99M1.323.32 million shs2.16 million shsOWLTOwlet$4.94+2.9%$6.50$3.92▼$16.94$135.17M1.84220,213 shs215,278 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTKBCytek Biosciences0.00%+3.59%+1.99%-8.51%+19.69%FEIMFrequency Electronics0.00%+14.92%+16.84%+3.34%+210.97%LABStandard BioTools0.00%+3.73%+2.65%-30.96%-22.33%OWLTOwlet0.00%-7.84%-5.84%-62.61%+20.35%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTKBCytek Biosciences$4.78+2.6%$4.46$2.37▼$6.18$601.80M1.22571,972 shs793,359 shsFEIMFrequency Electronics$56.22+6.2%$50.63$16.77▼$61.47$521.03M0.53165,312 shs175,006 shsLABStandard BioTools$0.98+4.7%$0.97$0.87▼$1.72$364.99M1.323.32 million shs2.16 million shsOWLTOwlet$4.94+2.9%$6.50$3.92▼$16.94$135.17M1.84220,213 shs215,278 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTKBCytek Biosciences0.00%+3.59%+1.99%-8.51%+19.69%FEIMFrequency Electronics0.00%+14.92%+16.84%+3.34%+210.97%LABStandard BioTools0.00%+3.73%+2.65%-30.96%-22.33%OWLTOwlet0.00%-7.84%-5.84%-62.61%+20.35%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTKBCytek Biosciences 2.00Hold$5.3812.45% UpsideFEIMFrequency Electronics 2.50Moderate Buy$43.67-22.33% DownsideLABStandard BioTools 1.67Reduce$1.3537.90% UpsideOWLTOwlet 2.40Hold$20.00304.86% UpsideCurrent Analyst Ratings BreakdownLatest OWLT, CTKB, FEIM, and LAB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/24/2026LABStandard BioTools Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/21/2026OWLTOwlet Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/27/2026CTKBCytek Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/18/2026FEIMFrequency Electronics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B+) ➝ Hold (C+)3/6/2026OWLTOwlet TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy3/2/2026OWLTOwlet Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTKBCytek Biosciences$201.49M3.06N/AN/A$2.67 per share1.79FEIMFrequency Electronics$69.81M7.92$2.84 per share19.81$5.75 per share9.78LABStandard BioTools$85.33M4.48N/AN/A$1.10 per share0.89OWLTOwlet$105.70M1.32N/AN/A$0.71 per share6.96Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTKBCytek Biosciences-$66.54M-$0.51N/AN/AN/A-33.02%-7.70%-5.89%5/7/2026 (Estimated)FEIMFrequency Electronics$23.69M$0.7574.96N/AN/A10.78%12.69%7.84%7/9/2026 (Estimated)LABStandard BioTools-$74.90M-$0.20N/AN/AN/A-59.39%-11.21%-8.51%5/5/2026 (Estimated)OWLTOwlet-$39.68M-$2.71N/AN/AN/A-37.15%N/A-11.47%5/7/2026 (Estimated)Latest OWLT, CTKB, FEIM, and LAB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026CTKBCytek Biosciences-$0.08N/AN/AN/A$44.23 millionN/A5/7/2026Q1 2026OWLTOwlet-$0.18N/AN/AN/A$20.84 millionN/A5/5/2026Q1 2026LABStandard BioTools-$0.02$0.33+$0.35$0.33$17.80 million$21.15 million3/11/2026Q3 2026FEIMFrequency Electronics$0.3050$0.16-$0.1450$0.16$19.06 million$16.89 million3/5/2026Q4 2025OWLTOwlet-$0.13-$0.03+$0.10-$0.39$26.01 million$26.55 million2/26/2026Q4 2025CTKBCytek Biosciences$0.02-$0.34-$0.36-$0.34$58.80 million$62.14 million2/24/2026Q4 2025LABStandard BioTools-$0.03$0.05+$0.08$0.05$18.50 million$23.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCTKBCytek BiosciencesN/AN/AN/AN/AN/AFEIMFrequency ElectronicsN/AN/AN/AN/AN/ALABStandard BioToolsN/AN/AN/AN/AN/AOWLTOwletN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTKBCytek BiosciencesN/A5.044.42FEIMFrequency ElectronicsN/A2.601.32LABStandard BioToolsN/A4.194.01OWLTOwlet0.131.851.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTKBCytek Biosciences69.46%FEIMFrequency Electronics58.60%LABStandard BioTools53.74%OWLTOwlet72.60%Insider OwnershipCompanyInsider OwnershipCTKBCytek Biosciences10.33%FEIMFrequency Electronics28.00%LABStandard BioTools23.16%OWLTOwlet52.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTKBCytek Biosciences500129.14 million115.80 millionOptionableFEIMFrequency Electronics2009.84 million7.09 millionNot OptionableLABStandard BioTools620390.37 million299.96 millionOptionableOWLTOwlet10628.16 million13.46 millionNo DataOWLT, CTKB, FEIM, and LAB HeadlinesRecent News About These CompaniesOwlet Gives Moms the Ultimate Mother's Day Gift: More Confidence and Peace of MindMay 4 at 10:15 AM | tmcnet.comOwlet (NYSE:OWLT) Cut to "Strong Sell" at Wall Street ZenMay 2 at 2:17 AM | marketbeat.comOwlet (NYSE:OWLT) CEO Sells $15,618.35 in StockMay 1, 2026 | insidertrades.comJonathan Harris Sells 1,945 Shares of Owlet (NYSE:OWLT) StockApril 30, 2026 | marketbeat.comOwlet (NYSE:OWLT) CEO Jonathan Harris Sells 1,851 SharesApril 30, 2026 | marketbeat.comJonathan Harris Sells 3,315 Shares of Owlet (NYSE:OWLT) StockApril 30, 2026 | marketbeat.comAmanda Crawford Sells 4,225 Shares of Owlet (NYSE:OWLT) StockApril 30, 2026 | marketbeat.comJonathan Harris Sells 3,423 Shares of Owlet (NYSE:OWLT) StockApril 30, 2026 | marketbeat.comOwlet (NYSE:OWLT) CEO Sells $37,701.00 in StockApril 30, 2026 | marketbeat.comInsider Selling: Owlet (NYSE:OWLT) CFO Sells 6,892 Shares of StockApril 30, 2026 | marketbeat.comOwlet (NYSE:OWLT) CEO Sells $145,774.00 in StockApril 30, 2026 | marketbeat.comOwlet (NYSE:OWLT) CEO Sells $415,013.76 in StockApril 30, 2026 | marketbeat.comEarnings Preview: Owlet, Inc. (OWLT) Q1 Earnings Expected to DeclineApril 30, 2026 | zacks.comOwlet (OWLT) Expected to Announce Earnings on ThursdayApril 30, 2026 | marketbeat.comKLA (KLAC) Surpasses Q3 Earnings and Revenue EstimatesApril 29, 2026 | zacks.comOwlet to Report First Quarter 2026 Financial Results on May 7, 2026April 23, 2026 | businesswire.comOwlet, Inc. (NYSE:OWLT) Given Consensus Rating of "Hold" by BrokeragesApril 20, 2026 | marketbeat.comOwlet, Inc. Class AApril 16, 2026 | edition.cnn.comOwlet Launches New Employer Benefit Program, Empowering Companies to Support Parents with Medical-Grade Infant Health MonitoringApril 16, 2026 | businesswire.comAnalysts Offer Insights on Healthcare Companies: Owlet (OWLT) and Becton Dickinson (BDX)April 11, 2026 | theglobeandmail.comNorthland Securities Has Weak Outlook for Owlet Q2 EarningsApril 9, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOWLT, CTKB, FEIM, and LAB Company DescriptionsCytek Biosciences NASDAQ:CTKB$4.78 +0.12 (+2.58%) Closing price 04:00 PM EasternExtended Trading$4.80 +0.01 (+0.31%) As of 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.Frequency Electronics NASDAQ:FEIM$56.22 +3.28 (+6.20%) Closing price 04:00 PM EasternExtended Trading$54.60 -1.62 (-2.88%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Frequency Electronics, Inc., together with its subsidiaries, engages in designing, development, and manufacturing of precision time and frequency control products and components for microwave integrated circuit applications. It operates through two segments, FEI-NY and FEI-Zyfer. The FEI-NY segment offers precision time and frequency control products for communication satellites, terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military; and provides design and technical support for satellite business. FEI-Zyfer segment offers global positioning system technologies to systems and subsystems for secure communications, both government and commercial, and other locator applications; and engages in sale and support of wireline telecommunications products, including US5G. It markets its products directly and through independent sales representative organizations located in the United States, Europe, and Asia. Frequency Electronics, Inc. was founded in 1961 and is headquartered in Mitchel Field, New York.Standard BioTools NASDAQ:LAB$0.98 +0.04 (+4.71%) Closing price 04:00 PM EasternExtended Trading$1.00 +0.02 (+1.63%) As of 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.Owlet NYSE:OWLT$4.94 +0.14 (+2.92%) Closing price 03:59 PM EasternExtended Trading$5.52 +0.58 (+11.68%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
